from january 1975 to may 1981 , 25 consecutive patients with multiple myeloma ( mm ) were entered in a prospective study and treated with the m-2 protocol ( melphalan , prednisone , cyclophosphamide , vincristine , and carmustine [ bcnu ] ) .
C0065442
m-2 protocol
C0032952
prednisone